Repros Therapeutics Inc. to Present Androxal® and Proellex® Clinical Updates at the Lazard Capital Markets 9th Annual Healthcare Conference

Published: Nov 05, 2012

THE WOODLANDS, Texas, Nov. 5, 2012 (GLOBE NEWSWIRE) -- Repros Therapeutics Inc.® (Nasdaq:RPRX)today announced the Company will present clinical updates for both its Androxal® and Proellex® programs Wednesday, November 14, 2012, at 8 am Eastern time. The Company is not webcasting the presentation but will have the slides available on its website, www.reprosrx.com, the morning of the presentation.

Back to news